Login
$TVRD
$0.87 +$0.02 (2.76%) Close

$TVRD 8-K/A SEC Filings

Filed On Filing
13 May 2025 8-K/A: Completion of Acquisition or Disposition of Assets

Condensed balance sheets as of March 31, 2025 and December 31, 2024

20 Dec 2024 8-K/A: Financial Statements and Exhibits

2 Disclaimer and Forward-Looking Statements This presentation and any accompanying oral commentary have been prepared by Tvardi Therapeutics, Inc. (“Tvardi”) and Cara Therapeutics, Inc. (“Cara”) for informational purposes only and to ass...

11 Aug 2020 8-K/A: Submission of Matters to a Vote of Security Holders

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support